Cromwell Holdings’s Gilead Sciences GILD Stock Holding History

Cromwell Holdings’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Buy	3,186 +1	+0%	+$132	0.18%	100
2026 Q1	$444K	Hold	3,185	–	–	0.25%	70
2025 Q4	$391K	Hold	3,185	–	–	0.21%	90
2025 Q3	$354K	Hold	3,185	–	–	0.19%	101
2025 Q2	$353K	Hold	3,185	–	–	0.21%	91
2025 Q1	$357K	Hold	3,185	–	–	0.23%	89
2024 Q4	$294K	Hold	3,185	–	–	0.17%	104
2024 Q3	$267K	Hold	3,185	–	–	0.17%	118
2024 Q2	$219K	Buy	+3,185	New	+$213K	0.13%	137

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Cromwell Holdings's GILD Position: Q2 2026 in Review

Cromwell Holdings increased its Gilead Sciences (GILD) stake by 0.03% in Q2 2026, buying an estimated $132 and bringing the position to 3,186 shares worth $403K. The position accounts for 0.18% of the portfolio, ranked #100.

Cromwell Holdings first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. The position peaked at $444K in Q1 2026. 615 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Cromwell Holdings held 3,186 shares of Gilead Sciences worth $403K as of Q2 2026.
Cromwell Holdings bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
Gilead Sciences made up 0.18% of Cromwell Holdings's portfolio in Q2 2026, its #100 holding.
Cromwell Holdings first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
Cromwell Holdings's Gilead Sciences position peaked at $444K in Q1 2026.
615 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.